Stock IdeasStrong Buy Stocks

Strong Buy Stocks from Top Wall Street Analysts

Latest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen

BTIG's Mark Massaro raised their price target on Natera (NASDAQ: NTRA) by 8% from $250 to $270 on 2026/06/24. The analyst maintained their Strong Buy rating on the stock.

Raising their price target on Natera, Massaro called Signatera's jumping into NCCN guidelines a "major catalyst" for the company, the stock, and the precision oncology field.

Although Signatera is routinely used today by about 50% of medical oncologists, NCCN guideline inclusion will help advance utilization and penetration up over 70% with time, the analyst explained.